Evidence map›Paper›PMID 30523437›Full record

ArticleJournal of cheminformatics2018

Chemlistem: chemical named entity recognition using recurrent neural networks.

Peter Corbett, John Boyle

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Chemical Entity Recognition for MEDLINE Indexing.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Finding medication doses in the liteature.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2018
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Peter CorbettData Science Group, Technology Department, The Royal Society of Chemistry, Cambridge, UK. corbettp@rsc.org.ORCID http://orcid.org/0000-0002-3029-8325
John BoyleData Science Group, Technology Department, The Royal Society of Chemistry, Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical named entity recognition (NER) has traditionally been dominated by conditional random fields (CRF)-based approaches but given the success of the artificial neural network techniques known as "deep learning" we decided to examine them as an alternative to CRFs. We present here several chemical named entity recognition systems. The first system translates the traditional CRF-based idioms into a deep learning framework, using rich per-token features and neural word embeddings, and producing a sequence of tags using bidirectional long short term memory (LSTM) networks-a type of recurrent neural net. The second system eschews the rich feature set-and even tokenisation-in favour of character labelling using neural character embeddings and multiple LSTM layers. The third system is an ensemble that combines the results of the first two systems. Our original BioCreative V.5 competition entry was placed in the top group with the highest F scores, and subsequent using transfer learning have achieved a final F score of 90.33% on the test data (precision 91.47%, recall 89.21%).

Indexed as

ChemicalsDeep learningNamed entity recognition

Identifiers

PMID30523437
PMCPMC6755713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.